Serum Antibody Levels to the Pneumocystis jirovecii Major Surface Glycoprotein in the Diagnosis of P. jirovecii Pneumonia in HIV+ Patients

Quantification and Spread ofPneumocystis jiroveciiin the Surrounding Air of Patients withPneumocystisPneumonia

(2010) Firas Choukri et al.   CLINICAL INFECTIOUS DISEASES

Evidence for high prevalence of Pneumocystis jirovecii exposure among Cameroonians

(2009) Stephenson W. Nkinin et al.   ACTA TROPICA

Serum (1→3) β‐d‐Glucan as a Noninvasive Adjunct Marker for the Diagnosis ofPneumocystisPneumonia in Patients with AIDS

(2009) Tamayo Watanabe et al.   CLINICAL INFECTIOUS DISEASES

Geographical variation in serological responses to recombinant Pneumocystis jirovecii major surface glycoprotein antigens

(2009) K. Daly et al.   CLINICAL MICROBIOLOGY AND INFECTION

Pneumocystis Pneumonia: Current Concepts in Pathogenesis, Diagnosis, and Treatment

(2009) Bryan J. Krajicek et al.   CLINICS IN CHEST MEDICINE

Long‐Term Serologic Responses to thePneumocystis jiroveciiMajor Surface Glycoprotein in HIV‐Positive Individuals With and WithoutP. jiroveciiInfection

(2009) Peter D. Walzer et al.   JOURNAL OF INFECTIOUS DISEASES

Relationship ofPneumocystisAntibody Response to Severity of Chronic Obstructive Pulmonary Disease

(2008) Alison Morris et al.   CLINICAL INFECTIOUS DISEASES

Early Predictors of Mortality from Pneumocystis jirovecii Pneumonia in HIV-Infected Patients: 1985-2006

(2008) P. D. Walzer et al.   CLINICAL INFECTIOUS DISEASES

Use of a Serum β‐Glucan Assay for Diagnosis of HIV‐RelatedPneumocystis jiroveciPneumonia in Patients with Negative Microscopic Examination Results

(2008) Mary L. Pisculli et al.   CLINICAL INFECTIOUS DISEASES

Pneumocystis colonisation is common among hospitalised HIV infected patients with non-Pneumocystis pneumonia

(2007) J L Davis et al.   THORAX

B cell immunopathology during HIV-1 infection: Lessons to learn for HIV-1 vaccine design

(2007) Alberto Cagigi et al.   VACCINE